SARS CoV 2 News and Research

RSS

Study: Drinking honeysuckle decoction accelerates the negative conversion of COVID-19 patients

In a new study in Cell Discovery, Chen-Yu Zhang's group at Nanjing University and two other groups from Wuhan Institute of Virology and the Second Hospital of Nanjing present a novel finding that absorbed miRNA MIR2911 in honeysuckle decoction (HD) can directly target SARS-CoV-2 genes and inhibit viral replication. Drinking of HD accelerate the negative conversion of COVID-19 patients.

7 Aug 2020

Immune system derails during severe course of COVID-19

Contrary to what has been generally assumed so far, a severe course of COVID-19 does not solely result in a strong immune reaction - rather, the immune response is caught in a continuous loop of activation and inhibition.

6 Aug 2020

Study shows recombination among SARS-CoV-2 strains is already occurring, but remains rare

A recent study by U.S. researchers, currently available on the bioRxiv preprint server, indicates that the recombination events among the viral strains of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are already occurring – however, considering current levels of viral genetic diversity, they are neither widespread nor readily detectable.

6 Aug 2020

Heat suggested as a therapeutic intervention in COVID-19

Viruses that are contained within a lipid membrane or “enveloped viruses” such as coronaviruses and rhinoviruses can remain active for long periods in cool, dry conditions, which can lead to increased rates of respiratory infections.

6 Aug 2020

COVID-19 in pregnancy - premature birth common

A new study conducted by researchers at Yonsei University College of Medicine, Korea, suggests that while having coronavirus disease 2019 (COVID-19) during pregnancy has little effect on fetal or neonatal mortality, it can be associated with premature birth and sometimes severe outcomes for mother and baby, including death.

6 Aug 2020

Racial disparities related to outcomes exist among stroke patients

Two new studies indicate that racial disparities related to outcomes exist among stroke patients, including one study that specifically examines stroke patients with COVID-19.

6 Aug 2020

COVID-19: BCG vaccine is safe and possibly has a positive effect

The BCG vaccine, a vaccine originally made against tuberculosis, has a general stimulating effect on the immune system and is therefore effective against multiple infectious diseases - possibly also against COVID-19.

6 Aug 2020

COST Actions to deal with COVID-19 crisis

The current COVID-19 crisis puts the world to the test, and research and innovation will be key in tackling this enormous challenge.

6 Aug 2020

Nine teams awarded UTHSC/UofM CORNET grant for COVID-19 research

Nine research teams are awardees of the 2020 University of Tennessee Health Science Center/University of Memphis SARS-CoV-2/COVID-19 Research CORNET grants.

6 Aug 2020

Vela Diagnostics' coronavirus PCR test receives Emergency Use Authorization from FDA

Vela Diagnostics announced that the manual version of its coronavirus PCR test has obtained Emergency Use Authorization from the U.S. Food and Drug Administration.

6 Aug 2020

Fujirebio announces launch of clinical testing for new SARS-CoV-2 Antigen assay

Fujirebio Diagnostics, Inc., a consolidated subsidiary of H.U. Group Holdings, Inc, announced today the initiation of clinical testing needed for the submission of its new SARS-CoV-2 Antigen assay for EUA (Emergency Use Authorization) from the U.S. Food and Drug Administration.

6 Aug 2020

Avacta appoints COVID-19 rapid antigen test manufacturing partner

Avacta Group plc is pleased to announce that it has appointed BBI Solutions to manufacture the saliva-based rapid SARS-CoV-2 antigen test.

From Avacta Life Sciences Ltd. 6 Aug 2020

Human encroachment into forest land caused bat CoV spillover and COVID-19 emergence

A new study published on the preprint server medRxiv in August 2020 discusses the root causes underlying the emergence of such infectious diseases following their crossover of the line separating animal viruses from human. This initial event is of enormous significance.

6 Aug 2020

Carefully engineered spike protein can help develop COVID-19 vaccine

The experimental vaccine against SARS-CoV-2 that was the first to enter human trials in the United States has been shown to elicit neutralizing antibodies and a helpful T-cell response with the aid of a carefully engineered spike protein that mimics the infection-spreading part of the virus.

6 Aug 2020

Face masks protect from COVID-19 and other respiratory illnesses

Now a new study published on the preprint server medRxiv in August 2020, therefore, presents the results of a meta-analysis that takes account of the lack of compliance with mask-wearing in RCTs, as well as the lag between the event and the measurable effects.

6 Aug 2020

Cats susceptible to and potential reservoirs for novel coronavirus

The study published on the preprint server bioRxiv in August 2020 shows that this is indeed taking place, with pet cats being infected and passing on the infection to contacts. It also offers the chance to see how the disease progresses in a susceptible host.

6 Aug 2020

Fast, cheap and easy COVID-19 test from Yale

As a result, a new study by Yale University researchers and published on the preprint server medRxiv in August 2020 shows that a new saliva test named SalivaDirect simplifies the test approach, avoids invasive samples collection, and the need for trained personnel to collect specimens.

6 Aug 2020